|4Aug 21, 4:01 PM ET

ANDO GORAN 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Aug 21, 2024

Insider Transaction Report

Form 4
Period: 2024-08-21
ANDO GORAN
Director
Transactions
  • Purchase

    Common Stock

    2024-08-21$7.95/sh+5,000$39,75013,150 total

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT